Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty.

@article{Birand1997EffectsOT,
  title={Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty.},
  author={A Birand and Gulmira Z Kudaiberdieva and Talantbek A. Batyraliev and Ferit Akgul and Ayhan Usal},
  journal={Angiology},
  year={1997},
  volume={48 5},
  pages={413-22}
}
Fifty-one patients (mean age 51.6 +/- 7.1 years) with angiographically proven coronary artery disease (CAD) entered the study. In 26 patients (Group I), trimetazidine treatment started twenty-four hours after percutaneous transluminal coronary angioplasty (PTCA). Another 25 patients (Group II) without trimetazidine treatment were kept as controls. The… CONTINUE READING